DGAP-News: Veloxis Pharmaceuticals A/S completes fully subscribed rights issue
(firmenpresse) - Veloxis Pharmaceuticals A/S
13.11.2012 09:24
---------------------------------------------------------------------------
Not for release, publication or distribution in the United States, Canada,
Australia or Japan
This announcement does not constitute an offer to sell or the solicitation of
an offer to buy the securities of Veloxis Pharmaceuticals A/S (the
'Securities') in the United States or in any other jurisdiction. The Securities
may not be offered or sold in the United States absent registration or an
exemption from registration under the U.S. Securities Act of 1933, as amended.
The issuer of the Securities has not registered, and does not intend to
register, any portion of the Offering in the United States or in any
jurisdiction outside Denmark, and does not intend to conduct a public offering
of the Securities in the United States or in any other jurisdiction outside
Denmark. Copies of this announcement are not being made and may not be
distributed or sent into the United States, Canada, Australia or Japan or any
other jurisdiction where such distribution is not permitted under the
applicable laws of such jurisdiction.
The company announcement is attached.
Click on, or paste the following link into your web browser, to view the associated documents
https://newsclient.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=409784
News Source: NASDAQ OMX
13.11.2012 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Veloxis Pharmaceuticals A/S
Dänemark
Phone:
Fax:
E-mail:
Internet:
ISIN: DK0060048148
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 13.11.2012 - 09:24 Uhr
Sprache: Deutsch
News-ID 202466
Anzahl Zeichen: 2984
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 211 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Veloxis Pharmaceuticals A/S completes fully subscribed rights issue"
steht unter der journalistisch-redaktionellen Verantwortung von
Veloxis Pharmaceuticals A/S (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
